ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of …
JL Anderson, CD Adams, EM Antman… - Journal of the American …, 2007 - jacc.org
The ACC/AHA Task Force on Practice Guidelines was formed to make recommendations
regarding the diagnosis and treatment of patients with known or suspected cardiovascular …
regarding the diagnosis and treatment of patients with known or suspected cardiovascular …
Heparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
Abbreviations: ACT activated clotting time; APTT activated partial thromboplastin time; AT
antithrombin; AT-III antithrombin III; CI confidence interval; DVT deep vein thrombosis; GP …
antithrombin; AT-III antithrombin III; CI confidence interval; DVT deep vein thrombosis; GP …
Prevalence of conventional risk factors in patients with coronary heart disease
UN Khot, MB Khot, CT Bajzer, SK Sapp, EM Ohman… - Jama, 2003 - jamanetwork.com
ContextIt is commonly suggested that more than 50% of patients with coronary heart disease
(CHD) lack any of the conventional risk factors (cigarette smoking, diabetes, hyperlipidemia …
(CHD) lack any of the conventional risk factors (cigarette smoking, diabetes, hyperlipidemia …
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST …
JP Bassand, CW Hamm, D Ardissino… - European heart …, 2007 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …
for personal and educational use only. No commercial use is authorized. No part of the ESC …
2012 accf/aha focused update of the guideline for the management of patients with unstable angina/non–st-elevation myocardial infarction (updating the 2007 …
2012 Writing Committee Members, H Jneid… - Circulation, 2012 - Am Heart Assoc
The standing guideline writing committee along with the parent Task Force identified trials
and other key data through October 2011 that may impact guideline recommendations. On …
and other key data through October 2011 that may impact guideline recommendations. On …
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial …
2007 Writing Committee Members, JL Anderson… - Circulation, 2013 - Am Heart Assoc
It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …
use of diagnostic procedures and therapies as they are introduced and tested in the …
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 …
2011 Writing Group Members, RS Wright… - Circulation, 2011 - Am Heart Assoc
Late-breaking clinical trials presented at the 2008 and 2009 annual scientific meetings of the
ACC, AHA, and European Society of Cardiology, as well as selected other data through April …
ACC, AHA, and European Society of Cardiology, as well as selected other data through April …
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials
E Boersma, RA Harrington, DJ Moliterno, H White… - The Lancet, 2002 - thelancet.com
Summary Background Platelet glycoprotein IIb/IIIa inhibitors have been shown to reduce
cardiac complications in patients undergoing percutaneous coronary intervention. The …
cardiac complications in patients undergoing percutaneous coronary intervention. The …
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
PURSUIT Trial Investigators - New England Journal of Medicine, 1998 - Mass Medical Soc
Background Aggregation of platelets is the pathophysiologic basis of the acute coronary
syndromes. Eptifibatide, a synthetic cyclic heptapeptide, is a selective high-affinity inhibitor …
syndromes. Eptifibatide, a synthetic cyclic heptapeptide, is a selective high-affinity inhibitor …
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non–Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction …
EM Antman, CH McCabe, EP Gurfinkel, AGG Turpie… - Circulation, 1999 - Am Heart Assoc
Background—Low-molecular-weight heparins are attractive alternatives to unfractionated
heparin (UFH) for management of unstable angina/non–Q-wave myocardial infarction …
heparin (UFH) for management of unstable angina/non–Q-wave myocardial infarction …